DOW JONES NEWSWIRES -- Millipore Corp. (MIL) said its proposed acquisition by pharmaceutical and chemicals company Merck KGaA (MRK.XE) did not raise antitrust concerns from federal regulators, according to a filing with the Securities and Exchange Commission.
